- Home
- CTNM vs SRV Comparison
CTNM vs SRV Comparison
Compare CTNM & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- SRV
- Stock Information
- Founded
- CTNM 2009
- SRV 2007
- Country
- CTNM United States
- SRV United States
- Employees
- CTNM N/A
- SRV N/A
- Industry
- CTNM
- SRV Finance Companies
- Sector
- CTNM
- SRV Finance
- Exchange
- CTNM Nasdaq
- SRV Nasdaq
- Market Cap
- CTNM 174.6M
- SRV 185.8M
- IPO Year
- CTNM 2024
- SRV N/A
- Fundamental
- Price
- CTNM $7.38
- SRV $43.77
- Analyst Decision
- CTNM Strong Buy
- SRV
- Analyst Count
- CTNM 4
- SRV 0
- Target Price
- CTNM $22.50
- SRV N/A
- AVG Volume (30 Days)
- CTNM 196.1K
- SRV 33.9K
- Earning Date
- CTNM 08-05-2025
- SRV 01-01-0001
- Dividend Yield
- CTNM N/A
- SRV 13.38%
- EPS Growth
- CTNM N/A
- SRV N/A
- EPS
- CTNM N/A
- SRV N/A
- Revenue
- CTNM N/A
- SRV N/A
- Revenue This Year
- CTNM N/A
- SRV N/A
- Revenue Next Year
- CTNM N/A
- SRV N/A
- P/E Ratio
- CTNM N/A
- SRV N/A
- Revenue Growth
- CTNM N/A
- SRV N/A
- 52 Week Low
- CTNM $3.35
- SRV $30.73
- 52 Week High
- CTNM $20.55
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- SRV 59.59
- Support Level
- CTNM N/A
- SRV $42.26
- Resistance Level
- CTNM N/A
- SRV $44.45
- Average True Range (ATR)
- CTNM 0.00
- SRV 0.66
- MACD
- CTNM 0.00
- SRV 0.09
- Stochastic Oscillator
- CTNM 0.00
- SRV 62.35
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.